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Abstract
Less than half of gay and bisexual men indicated they had received any doses of hepatitis B virus
(HBV) vaccine. HBV vaccination was higher among men who were 18-29 years old (compared to
those 50-59 years old), gay, or had received flu vaccine within the last year.
Hepatitis B virus (HBV) infection is of particular concern for gay and bisexual men, as
11%-20% have serological evidence of past or current infection.1-4 HBV vaccine was
recommended for groups at high risk for infection in 1985, including men who have sex
with men.5 The Advisory Committee on Immunization Practices (ACIP) continues to
recommend HBV vaccination for high-risk individuals, as well as any other adult who wants
the vaccine.6 Despite these recommendations, only 9% to 42% of gay and bisexual men in
the US have received any doses of HBV vaccine.3,7-12 Many of these studies, however, used
convenience sampling from only one geographic area, and it has been almost a decade since
data for the most recent of these studies were collected. In the interim, new programs
integrating HBV vaccination into STD clinic services, HIV testing, and syringe exchange
programs have been implemented as a way to increase HBV vaccination among gay and
bisexual men and other high-risk adults.13-17 In this report, we characterize recent HBV
vaccination rates among a national sample of gay and bisexual men.
The University of North Carolina Men’s Health Survey interviewed men aged 18-59 years
who were members of an existing national panel of U.S. households. The survey company
identified prospective panel members using list-assisted, random-digit dialing of landline
phones. Upon recruitment into the panel, the company collects demographic information,
including self-reported sexual orientation, through a background survey. Panel members
receive emails inviting them to complete multiple internet-based surveys each month, for
which they receive free internet access. Panel members with existing computer and internet
access accumulate points for completing surveys, which can be redeemed for small cash
payments.
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In January 2009, we randomly sampled male panel members who had reported their sexual
orientation in their background survey, oversampling men who self-identified as either gay
or bisexual. Of 874 men invited to participate, 609 (70%) completed our cross-sectional,
online survey.18 Response rates were higher among gay and bisexual men compared to
heterosexual men (79% vs. 62%). We report data from 306 men who self-identified as either
gay or bisexual, excluding all other participants. The Institutional Review Board at our
university approved the study.
We assessed HBV vaccination by asking, “The hepatitis B vaccine is a series of three shots.
How many hepatitis B vaccine shots, if any, have you had?” Response options included
“none”, “one”, “two”, “three”, “at least one shot, but don’t know how many,” and “I don’t
know if I had any shots”. We classified participants as “vaccinated” (one or more doses
received including those who indicated at least one shot but unsure of how many) or “not
vaccinated” (all other responses). Although primary HBV vaccination for adults consists of
three doses,6 we defined vaccination as receipt of one of more doses since adequate
immunity can develop in some individuals with fewer than three doses,6,19,20 and because
some younger participants may have received the two-dose adolescent HBV vaccine
regimen.21
Participants provided information on demographic variables and health behaviors (Table 1).
We assessed sexual orientation by asking, “Do you think of yourself as…..” with response
options of “gay or homosexual (attracted to men)”, “bisexual (attracted to men and
women)”, “heterosexual or straight (attracted to women)”, “something else”, and “not sure”.
We defined “urban” as living in a metropolitan statistical area (MSA) and “rural” as living
outside of an MSA.22 Participants provided self-reported histories of infection with human
immunodeficiency virus (HIV), HBV, and any other sexually transmitted infections (STIs).
Analyses excluded 14 men with a self-reported history of HBV infection, resulting in an
analytic sample size of 292. We used logistic regression to examine bivariate correlates of
HBV vaccination. Statistically significant bivariate correlates (p<0.05) were simultaneously
entered into a multivariate logistic regression model. We analyzed unweighted data using
SPSS version 17.0 (SPSS Inc., Chicago IL). All statistical tests were two-tailed, using a
critical alpha of 0.05.
Most participants were non-Hispanic white (80%), less than 50 years old (61%), had a
college degree (55%), and reported a household income of at least $60,000 (60%). Most
men had not initiated sex before age 16 (64%), indicated five or more lifetime sexual
partners (88%), and fewer than five male sexual partners in the last year (75%). Sixty-one
percent had disclosed to their primary healthcare provider that they have had sex with men,
16% reported a history of HIV infection, and 30% reported a history of other STIs.
Overall, 46% (133/292; 95% confidence interval [CI]: 40%–52%) of men indicated they had
received one or more doses of HBV vaccine. Most men reporting HBV vaccination
indicated they had received three doses (71%, 95/133), with fewer reporting two doses (5%,
7/133), one dose (6%, 8/133), or at least one dose but unsure of how many (17%, 23/133).
Among men considered to be unvaccinated (n=159), 114 indicated they had received no
doses, 43 did not know if they had received any does, and 2 had missing data.
In multivariate analyses (Table 1), HBV vaccination was higher among men aged 18-29
years compared to men aged 50-59 years (odds ratio [OR]=10.00, 95% CI: 2.36–42.36).
HBV vaccination was also higher among men who self-identified as gay (OR=2.03, 95% CI:
1.03–3.99) or had received flu vaccine within the last year (OR=1.88, 95% CI: 1.10–3.19).
We conducted extensive sensitivity analyses to explore the effect of classifying men who did
not know if they had received any does of HBV vaccine or had missing data as “not
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vaccinated”. Multivariate correlates did not differ greatly in these analyses, giving us
confidence in our findings.
Less than half of gay and bisexual men in this national sample indicated receiving any doses
of HBV vaccine, a rate only slightly higher than previous estimates among this population
(31%-42%)7-10,12 and males in general in the US (30%).23 Our results provide an important
update and suggest HBV vaccination in this high-risk population remains suboptimal. This
may be partly attributable to the lack of a national program for vaccinating uninsured or
underinsured adults and low usage of reimbursement programs among insured adults.6
Recent programs have sought to overcome these obstacles and reach high-risk adults.
Integration of HBV vaccination into STD clinic services, HIV testing, and syringe exchange
programs has been mostly successful in increasing vaccination rates.13-17 One such program
achieved 81% coverage (one or more doses) among men who have sex with men who were
return clients to an STD clinic.14 Greater availability of these programs and novel
approaches for reaching gay and bisexual men who do not attend these venues are needed.
Similar to past studies,8,9 younger men reported HBV vaccination more frequently. This
likely reflects US national recommendations to vaccinate children and adolescents against
HBV (occurred in 1991 and 1997, respectively24,25) and HBV vaccine school mandates.
Currently, 46 states have elementary or middle school mandates for HBV vaccination,26 and
19 states have some type of mandate for college entry.27 These policies would likely not
have been in effect for men over age 30 in our study. Since more than 80% of people aged
40 and older produce a protective antibody response after three doses of HBV vaccine,28
older gay and bisexual men can still benefit from vaccination.
HBV vaccination was higher among gay men compared to bisexual men, as in past research.
9 One potential explanation is that more gay men than bisexual men had disclosed to their
primary care providers that they have had sex with men (73% vs. 22%, p<0.001), causing
healthcare providers to recognize the need for and recommend HBV vaccination. Healthcare
providers should provide environments that facilitate both gay and bisexual men disclosing
their sexual behaviors, possibly by posting non-discrimination statements in their clinics and
using gender-neutral language about sexual partners.29 Lastly, HBV vaccination was more
common among men reporting flu vaccination within the last year, possibly due to their
greater use of health services or higher acceptability of vaccines in general.
Our study has several important strengths including the use of a national sample, a high
participation rate, and focusing on a high-risk population. Limitations include a cross-
sectional study design and self-reported HBV vaccination, though most gay men accurately
recall their HBV vaccination status.2 We did not have data on medical conditions that may
contraindicate HBV vaccination or on some factors that may indicate vaccination (e.g.,
history of drug use). Also, 60 men did not have data available on prior HBV infection,
though it is likely only a few had been previously infected. Data did not allow for
examination of history of individual STIs other than HIV. Although our sample came from a
study panel that closely resembles the U.S. population,30,31 most participants were older
than 30 years of age, non-Hispanic white, and of high socioeconomic status. At the time of
our study, the survey company recruited panel members only using list-assisted, random-
digit dialing of landline phones. Despite these limitations, our study provides a needed
update on HBV vaccination rates among gay and bisexual men in the US. Results indicate
vaccination rates remain suboptimal and suggest continued efforts to ensure vaccination are
needed.
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Among a national sample of gay and bisexual men, we found less than half indicated they
had received one or more doses of hepatitis B virus (HBV) vaccine.
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 18-29 11/14 (79) 5.54 (1.46-20.97)* 10.00 (2.36-42.36)**
 30-39 23/45 (51) 1.58 (0.79-3.17) 1.83 (0.88-3.83)
 40-49 54/120 (45) 1.24 (0.73-2.08) 1.25 (0.73-2.16)
 50-59 45/113 (40) ref. ref.
Sexual Self-Identity
 Bisexual 20/68 (29) ref. ref.
 Gay 113/224 (50) 2.44 (1.36-4.38)** 2.03 (1.03-3.99)*
Race / Ethnicity
 White, Non-Hispanic 105/233 (45) 0.91 (0.51-1.61) --
 Other Race / Ethnicity 28/59 (48) ref. --
Marital Status
 Divorced, Widowed, Separated,
Never Married 64/156 (41) ref. --
 Living with Partner or Married 69/136 (51) 1.48 (0.93-2.35) --
Education
 No College Degree 54/131 (41) ref. --
 College Degree 79/161 (49) 1.37 (0.86-2.19) --
Annual Household Income
 <$60,000 48/118 (41) ref. --
 ≥$60,000 85/174 (49) 1.39 (0.87-2.23) --
Employment Status
 Not Currently Employed 22/59 (37) ref. --
 Currently Employed 111/233 (48) 1.53 (0.85-2.75) --
Health Insurance Status
 No 14/43 (33) ref. --
 Yes 119/249 (48) 1.90 (0.96-3.76) --
Urbanicity
 Rural 8/20 (40) ref. --
 Urban 125/272 (46) 1.28 (0.51-3.22) --
Region of Residence
 Northeast 21/43 (49) ref. --
 Midwest 33/70 (47) 0.93 (0.44-2.00) --
 South 46/104 (44) 0.83 (0.41-1.69) --
 West 33/75 (44) 0.82 (0.39-1.75) --
Health and Health Behaviors
Received Flu Vaccine Within the























 No / Missing 83/200 (42) ref. ref.
 Yes 50/92 (54) 1.68 (1.02-2.76)* 1.88 (1.10-3.19)*
Age at First Sexual Intercourse
(Years)
 <16 49/106 (46) 1.04 (0.65-1.69) --
 ≥16 84/186 (45) ref. --
Number of Lifetime Sexual Partners
(Vaginal, Anal or Oral Intercourse)
 <5 16/35 (46) ref. --
 ≥5 117/257 (46) 0.99 (0.49-2.02) --
Number of Male Partners (Anal or
Oral Intercourse) in Last Year
 <5 97/218 (45) ref. --
 ≥5 36/74 (49) 1.18 (0.70-2.00) --
Disclosed Sex with Men to Primary
Healthcare Provider
 No 26/76 (34) ref. ref.
 Yes 95/178 (53) 2.20 (1.26-3.85)** 1.70 (0.89-3.24)
 Not Applicable / Missing 12/38 (32) 0.89 (0.39-2.04) 0.76 (0.32-1.85)
Most Recent HIV Test
 Within the Last Year 53/98 (54) 1.68 (1.03-2.74)* 1.31 (0.77-2.23)
 Not Within the Last Year 80/194 (41) ref. ref.
HIV Status
 Negative 107/245 (44) ref. --
 Positive 26/47 (55) 1.60 (0.85-2.99) --
Other Prior STI
 No 90/203 (44) ref. --
 Yes 43/89 (48) 1.17 (0.71-1.93) --
Note. Vaccination defined as receipt of one of more doses of HBV vaccine. The multivariate model did not include variables with dashes (--). HBV
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